Broker tips big gains and yields from NIB shares

Goldman Sachs is saying good things about this health insurance provider.

| More on:
A medical specialist holds a red heart connected via technology and artificial intelligence (AI)

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

NIB Holdings Limited (ASX: NHF) shares are ending the week on a positive note.

In late morning trade, the health insurance company's shares are up 0.5% to $7.59.

This latest gain means that its shares are now up over 6% since this time last year.

This compares favourably to a 2.5% decline by the ASX 200 index over the same period.

Can NIB shares keep rising?

Analysts at Goldman Sachs remain positive on the company and see scope for double-digit gains from current levels.

In response to quarterly data released by APRA, the broker has retained its buy rating and $8.40 price target on NIB's shares.

This implies a potential upside of 10.7% for investors over the next 12 months. In addition, the broker is forecasting a 3.8% dividend yield in FY 2024, boosting the total potential return to 14.5%.

It then expects dividend yields of 4.35% in FY 2025 and 4.6% in FY 2026.

What did the broker say?

Goldman believes that the data released by APRA supports is supportive of its positive view on NIB. It notes:

Relative to pre-Covid, we still think trends screen favourably for the health insurers across rate increases v benefit growth per insured life: Over the 12 mths to Sep-23 v pre Covid i.e. 12 mths to Sep-19, we still see positive jaws of underlying rate at an industry level over that period exceeding the growth in benefit per insured life. However, we do see strong benefit growth per insured life over 12 mth to Sep-23 v pcp (from a low base).

Why is it bullish?

Outside the above, there are a number of reasons why Goldman is bullish on NIB shares. The broker explains:

We are Buy-rated on NHF given: 1) it offers defensive exposure to the private health insurance sector which is experiencing favourable operating trends, 2) claims environment remains low with no immediate indications of a bounce back in claims, 3) DCL provisions to cover a bounce back in claims are proving redundant, 4) significant policyholder give back incentives suggest claiming environment remains well below expectations, 5) strong recovery in non-resident volume post Covid-19 through the return of international students, workers and visitor arrivals.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Guess which ASX 200 stock just jumped 9% on big news

Let's find out what is getting investors excited today.

Read more »